Bridging The Gap
As big pharma exits early-stage drug development, contract research firms are serving the nonprofit and government institutions that are taking it on
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
October 3, 2011 Cover
Volume 89, Issue 40
As big pharma exits early-stage drug development, contract research firms are serving the nonprofit and government institutions that are taking it on
Cover image:
Credit:
As big pharma exits early-stage drug development, contract research firms are serving the nonprofit and government institutions that are taking it on
Researchers are learning the secrets of mouse chemical communication by peering into their pee
Textile dyes: Industry migration to Asia continues
Solyndra’s bankruptcy triggers congressional investigation of Energy Department’s clean energy policies
Agent invites itself into the brain and then inhibits HIV enzyme
New players follow in the footsteps of lithium-ion battery makers to meet surging U.S. demand
For the first time, field tests show bioluminescence can function as a warning signal